Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
Background: there is clinical uncertainty about the effectiveness and safety of allergen immunotherapy (AIT) for the treatment of allergic asthma.
Objectives: to undertake a systematic overview of the effectiveness, cost-effectiveness and safety of AIT for the treatment of allergic asthma.
Methods: we searched nine electronic databases from inception to October 31, 2015. Systematic reviews were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme quality assessment tool for systematic reviews. Data were descriptively and thematically synthesized.
Results: we identified nine eligible systematic reviews; these focused on delivery of AIT through the following routes: subcutaneous (SCIT; n = 3); sublingual (SLIT; n = 4); and both SCIT and SLIT (n = 2). This evidence found that AIT delivered by SCIT and SLIT can improve medication and symptom scores and measures of bronchial hyper-reactivity. The impact on measures of lung function or asthma control was however less clear. We found no systematic review level evidence on the cost-effectiveness of SCIT or SLIT. SLIT had a favorable safety profile when compared to SCIT, particularly in relation to the risk of systemic reactions.
Conclusions: AIT has the potential to achieve reductions in symptom and medication scores, but there is no clear or consistent evidence that measures of lung function can be improved. Bearing in mind the limitations of synthesizing evidence from systematic reviews and the fact that these reviews include mainly dated studies, a systematic review of current primary studies is now needed to update this evidence base, estimate the effectiveness of AIT on asthma outcomes and to investigate the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT.
25
Asamoah, Felix
17b72649-9111-402f-9a34-6389f4ff0a70
Kakourou, Artemisia
c820a33e-7f5e-4565-bad3-1756511fd90e
Dhami, Sangeeta
13edaaf7-b3f8-40f8-be04-834cbe70f0a6
Lau, Susanne
66bbde71-a61f-42fa-8ddb-8a94edcb1017
Agache, Ioana
5a821a60-9456-48af-914b-476caa540f8f
Muraro, Antonella
c554bef5-502b-4540-a6f0-a3f7c37f0075
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Akdis, Cezmi
619835b1-c6a8-4cb5-b5eb-accc31e21f36
Bonini, Matteo
9d1c57e7-dc83-4eb2-9e1c-5cadd0c7fbf5
Cavkaytar, Ozlem
df9786a2-6e96-43c5-8934-e702412e7da1
Flood, Breda
0ef54fd2-7a49-4d76-ae99-ec79c6701d03
Izuhara, Kenji
78fca599-a635-4357-b0ca-7c03338f1ba5
Kalayci, Ömer
3d1ff4b6-3b71-4e6c-9762-320a86b6aefc
Pfaar, Oliver
e3f9b5dc-2e6d-4526-8a61-29024ff1c4b4
Sheikh, Aziz
5b7eb24b-0820-4bd6-8304-cc46bbe561a8
Asamoah, Felix
17b72649-9111-402f-9a34-6389f4ff0a70
Kakourou, Artemisia
c820a33e-7f5e-4565-bad3-1756511fd90e
Dhami, Sangeeta
13edaaf7-b3f8-40f8-be04-834cbe70f0a6
Lau, Susanne
66bbde71-a61f-42fa-8ddb-8a94edcb1017
Agache, Ioana
5a821a60-9456-48af-914b-476caa540f8f
Muraro, Antonella
c554bef5-502b-4540-a6f0-a3f7c37f0075
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Akdis, Cezmi
619835b1-c6a8-4cb5-b5eb-accc31e21f36
Bonini, Matteo
9d1c57e7-dc83-4eb2-9e1c-5cadd0c7fbf5
Cavkaytar, Ozlem
df9786a2-6e96-43c5-8934-e702412e7da1
Flood, Breda
0ef54fd2-7a49-4d76-ae99-ec79c6701d03
Izuhara, Kenji
78fca599-a635-4357-b0ca-7c03338f1ba5
Kalayci, Ömer
3d1ff4b6-3b71-4e6c-9762-320a86b6aefc
Pfaar, Oliver
e3f9b5dc-2e6d-4526-8a61-29024ff1c4b4
Sheikh, Aziz
5b7eb24b-0820-4bd6-8304-cc46bbe561a8
Asamoah, Felix, Kakourou, Artemisia, Dhami, Sangeeta, Lau, Susanne, Agache, Ioana, Muraro, Antonella, Roberts, Graham, Akdis, Cezmi, Bonini, Matteo, Cavkaytar, Ozlem, Flood, Breda, Izuhara, Kenji, Kalayci, Ömer, Pfaar, Oliver and Sheikh, Aziz
(2017)
Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews.
Clinical and Translational Allergy, 7, .
(doi:10.1186/s13601-017-0160-0).
Abstract
Background: there is clinical uncertainty about the effectiveness and safety of allergen immunotherapy (AIT) for the treatment of allergic asthma.
Objectives: to undertake a systematic overview of the effectiveness, cost-effectiveness and safety of AIT for the treatment of allergic asthma.
Methods: we searched nine electronic databases from inception to October 31, 2015. Systematic reviews were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme quality assessment tool for systematic reviews. Data were descriptively and thematically synthesized.
Results: we identified nine eligible systematic reviews; these focused on delivery of AIT through the following routes: subcutaneous (SCIT; n = 3); sublingual (SLIT; n = 4); and both SCIT and SLIT (n = 2). This evidence found that AIT delivered by SCIT and SLIT can improve medication and symptom scores and measures of bronchial hyper-reactivity. The impact on measures of lung function or asthma control was however less clear. We found no systematic review level evidence on the cost-effectiveness of SCIT or SLIT. SLIT had a favorable safety profile when compared to SCIT, particularly in relation to the risk of systemic reactions.
Conclusions: AIT has the potential to achieve reductions in symptom and medication scores, but there is no clear or consistent evidence that measures of lung function can be improved. Bearing in mind the limitations of synthesizing evidence from systematic reviews and the fact that these reviews include mainly dated studies, a systematic review of current primary studies is now needed to update this evidence base, estimate the effectiveness of AIT on asthma outcomes and to investigate the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT.
Text
s13601-017-0160-0
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 17 June 2017
e-pub ahead of print date: 1 August 2017
Identifiers
Local EPrints ID: 413312
URI: http://eprints.soton.ac.uk/id/eprint/413312
PURE UUID: a553d9dc-8c0c-43c5-a830-75a56b812b3a
Catalogue record
Date deposited: 21 Aug 2017 16:31
Last modified: 16 Mar 2024 03:44
Export record
Altmetrics
Contributors
Author:
Felix Asamoah
Author:
Artemisia Kakourou
Author:
Sangeeta Dhami
Author:
Susanne Lau
Author:
Ioana Agache
Author:
Antonella Muraro
Author:
Cezmi Akdis
Author:
Matteo Bonini
Author:
Ozlem Cavkaytar
Author:
Breda Flood
Author:
Kenji Izuhara
Author:
Ömer Kalayci
Author:
Oliver Pfaar
Author:
Aziz Sheikh
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics